Express Pharma

First Indian Pharmacovigilance Day conference to be held in Mumbai

1

Dr J Vijay Venkatraman, MD and CEO, Oviya MedSafe to chair the conference

The first ‘Indian Pharmacovigilance Day’ conference will be held in Mumbai on July 29, 2016. Dr J Vijay Venkatraman, Managing Director and Chief Executive Officer of Oviya MedSafe, a global pharmacovigilance consulting and drug safety services, will chair the conference.

During the conference, expert speakers from the industry, health authorities, research bodies, academia and healthcare delivery centres will share their perspectives on the multifaceted outlook of the discipline of pharmacovigilance in India and deliberate on the challenges they expect to face in 2016, covering several aspects of pharmacovigilance that India is involved in.

The ‘Pharmacovigilance Day’ is a series of conferences that has been organised in different parts of Europe by EasyB srl, an Italian company that specialises in producing conferences and seminars dedicated to the pharmaceutical sector such as clinical research, pharmacovigilance, statistics and epidemiology, across Europe, since 2008. The ‘Pharmacovigilance Day’ events aspire to bring together drug safety experts from the pharma and healthcare industry: pharma and medical devices companies, biotechnology firms, government agencies, academic research and so on, from a specific country or region with an aim to provide a platform for discussing pharmacovigilance issues that are unique to the concerned country/region.

Venkatraman said, “India is globally recognised as a hub for generic drug manufacturing and the Indian pharma industry has carved a niche for itself in exporting its products to many developed as well as emerging countries. Of late, India is also being seen as a target destination for procurement of support services required for the global pharma industry, especially in pharmacovigilance.”

Enrico Pedroni, Managing Director, EasyB srl based in Bergamo, Italy, expressed his happiness in organising their first event in India. “It was a pleasant experience for us to work with Dr J Vijay Venkatraman when he was the Chair of our first UK Pharmacovigilance Day. Hence, we felt we should organise the Indian Pharmacovigilance Day too with him at the helm of affairs,” he said.

Pedroni further said that the one-day conference has been designed to benefit functional / technical professionals working in the pharmacovigilance / regulatory / medical affairs / marketing domains in organisations involved in pharma manufacturing / drug marketing / contract research, healthcare professionals in patient care, clinical investigators and research staff, academia and government health agencies, among others.

Comments are closed.